Episode

E286 - GLP-1 Agonists in Psychiatry: Beyond Weight Loss with Dr. McIntyre

Podcast
NEI Podcast
Published
Jul 15, 2026
Duration seconds
3255
Processing state
not_requested
Canonical source
https://neiglobal.libsyn.com/e286-glp-1-agonists-in-psychiatry-beyond-weight-loss-with-dr-mcintyre
Audio
https://traffic.libsyn.com/secure/neiglobal/202607_McIntyre_A01SD.mp3?dest-id=507143
JSON
/v1/public/podcasts/nei-podcast-385769/episodes/e286-glp-1-agonists-in-psychiatry-beyond-weight-loss-with-dr-mcintyre
Markdown
/podcast/nei-podcast-385769/e286-glp-1-agonists-in-psychiatry-beyond-weight-loss-with-dr-mcintyre.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/nei-podcast-385769/episodes/e286-glp-1-agonists-in-psychiatry-beyond-weight-loss-with-dr-mcintyre/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/nei-podcast-385769/e286-glp-1-agonists-in-psychiatry-beyond-weight-loss-with-dr-mcintyre.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, Dr. Andy Cutler is joined by Dr. Roger McIntyre to discuss GLP-1 receptor agonists in psychiatry and why these medications may be relevant beyond weight loss. They explore the emerging role of GLP-1s in metabolic psychiatry, including potential connections with mood disorders, cognition, reward pathways, cardiometabolic health, and psychiatric medication-associated weight gain. Dr. McIntyre also discusses what psychiatric providers should know now, where the evidence is still evolving, and what future research is needed before GLP- 1 or incretin-based therapies could be considered part of psychiatric treatment. Roger S. McIntyre, MD, FRCPC, is Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto. He is an internationally recognized expert in mood disorders and psychopharmacology, with published scholarship and presentations exploring the relevance of GLP-1 receptor agonists to psychiatry. Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York. Fall Congress Get $100 off NEI Fall Congress registration with code POD26. Go to https://nei.global/fal l to sign up today! Membership As a valued NEI Podcast listener, Dr. Cutler's offering you 20% off new NEI Membership with code CUTLER20. Go to https://nei.global/member and join now! Never miss an episode! 🎙 SUBSCRIBE to the NEI Podcast – available on all your favorite platforms: https://nei.global/podcast I…